Calmy A - Search Results

1

Kaiser L, Vetter P, Calmy A, Manuel O, Calandra T. Kaiser L, et al. Among authors: calmy a. Rev Med Suisse. 2022 Apr 13;18(777):691-692. doi: 10.53738/REVMED.2022.18.777.691. Rev Med Suisse. 2022. PMID: 35417096 French. No abstract available.

2

Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study.

Osih RB, Taffé P, Rickenbach M, Gayet-Ageron A, Elzi L, Fux C, Opravil M, Bernasconi E, Schmid P, Günthard HF, Cavassini M; Swiss HIV Cohort Study. Osih RB, et al. AIDS Res Hum Retroviruses. 2010 Nov;26(11):1239-46. doi: 10.1089/aid.2010.0070. Epub 2010 Oct 7. AIDS Res Hum Retroviruses. 2010. PMID: 20929393 Free PMC article.

3

[Buruli ulcer and HIV: a complex and minimally studied interaction].

Christinet V, Di Benedetto C, Comte E, Calmy A. Christinet V, et al. Among authors: calmy a. Rev Med Suisse. 2012 Sep 19;8(354):1792-3. Rev Med Suisse. 2012. PMID: 23097918 French. No abstract available.

4

The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients.

Bibert S, Wojtowicz A, Taffé P, Manuel O, Bernasconi E, Furrer H, Günthard HF, Hoffmann M, Kaiser L, Osthoff M, Cavassini M, Bochud PY; Swiss HIV Cohort Study. Bibert S, et al. AIDS. 2014 Aug 24;28(13):1885-9. doi: 10.1097/QAD.0000000000000379. AIDS. 2014. PMID: 25259701 Free article.

5

Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.

Barceló C, Gaspar F, Aouri M, Panchaud A, Rotger M, Guidi M, Cavassini M, Buclin T, Decosterd LA, Csajka C; Swiss HIV Cohort Study. Barceló C, et al. J Antimicrob Chemother. 2016 Jul;71(7):1933-42. doi: 10.1093/jac/dkw050. Epub 2016 Mar 29. J Antimicrob Chemother. 2016. PMID: 27029846

6

[Antiretroviral treatments : towards simplified regimens ?].

Nawej Tshikung O, Calmy A. Nawej Tshikung O, et al. Among authors: calmy a. Rev Med Suisse. 2018 Jan 10;14(588-589):102-106. Rev Med Suisse. 2018. PMID: 29337462 French.

7

[Diagnosis, prevention and treatment of HIV : what's new in 2018 ?].

D'Incau S, Viala B, Ciuffi A, Cavassini M, Calmy A. D'Incau S, et al. Among authors: calmy a. Rev Med Suisse. 2019 Jan 9;15(N° 632-633):107-112. Rev Med Suisse. 2019. PMID: 30629381 Review. French.

8

[Novelties in HIV prevention and treatment in 2019].

Kampouri E, Papadimitriou-Olivgeris M, Calmy A, Ciuffi A, Cavassini M. Kampouri E, et al. Among authors: calmy a. Rev Med Suisse. 2020 Jan 15;16(676-7):92-98. Rev Med Suisse. 2020. PMID: 31961093 French.

9

[Integration of sexual medicine into the care of HIV patients].

Bolmont M, Bianchi-Demicheli F, Calmy A. Bolmont M, et al. Among authors: calmy a. Rev Med Suisse. 2020 Mar 18;16(686):539-542. Rev Med Suisse. 2020. PMID: 32186799 Review. French.

10

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral Treatment.

Pyngottu A, Scherrer AU, Kouyos R, Huber M, Hirsch H, Perreau M, Yerly S, Calmy A, Cavassini M, Stöckle M, Furrer H, Vernazza P, Bernasconi E, Günthard HF; Swiss HIV Cohort Study. Pyngottu A, et al. Among authors: calmy a. Clin Infect Dis. 2021 Oct 5;73(7):e2134-e2141. doi: 10.1093/cid/ciaa1614. Clin Infect Dis. 2021. PMID: 33095848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

647 results

Search Page